BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eirin A, Lerman LO. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet? Hypertension 2021;78:261-9. [PMID: 34176287 DOI: 10.1161/HYPERTENSIONAHA.121.14596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Hong S, Zhu X, Zhang L, Tang H, Jordan KL, Saadiq IM, Huang W, Lerman A, Eirin A, Lerman LO. IL-10 partly mediates the ability of MSC-derived extracellular vesicles to attenuate myocardial damage in experimental metabolic renovascular hypertension. Front Immunol 2022;13:940093. [DOI: 10.3389/fimmu.2022.940093] [Reference Citation Analysis]
2 Ipinmoroti AO, Pandit R, Matthews QL. Regenerative mesenchymal stem c ell‐derived extracellular vesicles: A potential alternative to c ell‐based therapy in viral infection and disease damage control. WIREs Mechanisms of Disease 2022. [DOI: 10.1002/wsbm.1574] [Reference Citation Analysis]
3 Tang TT, Wang B, Lv LL, Dong Z, Liu BC. Extracellular vesicles for renal therapeutics: State of the art and future perspective. J Control Release 2022:S0168-3659(22)00391-1. [PMID: 35779658 DOI: 10.1016/j.jconrel.2022.06.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Grange C, Bussolati B. Extracellular vesicles in kidney disease. Nat Rev Nephrol 2022. [PMID: 35641620 DOI: 10.1038/s41581-022-00586-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gao Z, Zhang C, Peng F, Chen Q, Zhao Y, Chen L, Wang X, Chen X. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation. Stem Cell Res Ther 2022;13:191. [PMID: 35526054 DOI: 10.1186/s13287-022-02861-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gutierrez AM, Frazar EM, X Klaus MV, Paul P, Hilt JZ. Hydrogels and Hydrogel Nanocomposites: Enhancing Healthcare through Human and Environmental Treatment. Adv Healthc Mater 2022;11:e2101820. [PMID: 34811960 DOI: 10.1002/adhm.202101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ma Y, Liu X, Long Y, Chen Y. Emerging Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Chronic Respiratory Diseases: An Overview of Recent Progress. Front Bioeng Biotechnol 2022;10:845042. [DOI: 10.3389/fbioe.2022.845042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Tang PM, Chen H, Tang Y, Nikolic-paterson DJ, Lan HY. Editorial: Immune Landscape of Kidney Pathology. Front Physiol 2022;12:827537. [DOI: 10.3389/fphys.2021.827537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chen YA, Lu CH, Ke CC, Liu RS. Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapy for Alzheimer's Disease: Progress and Opportunity. Membranes (Basel) 2021;11:796. [PMID: 34677562 DOI: 10.3390/membranes11100796] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 张 芷. The Research Progress of Mesenchymal Stem Cells’ Exosomes in the Treatment of Diabetic Nephropathy. ACM 2021;11:5905-5910. [DOI: 10.12677/acm.2021.1112875] [Reference Citation Analysis]